Relationship between changes in drug score, D-glucaric acid excretion, and gamma-glutamyltransferase and beta-glucuronidase serum activities during anticonvulsant treatment.
Clin Lab
; 48(7-8): 415-9, 2002.
Article
em En
| MEDLINE
| ID: mdl-12146576
ABSTRACT
The purpose of this study was to investigate the relationship of changes in the enzyme-inducing anticonvulsant daily dosage (drug score) to variations in urinary D-glucaric acid excretion and gamma-glutamyltransferase and beta-glucuronidase serum activities. These biochemical determinations were carried out before and after a mean period of 5.0 years in 16 adult epileptic patients (8 men and 8 women) treated with phenobarbital, phenytoin and/or carbamazepine and with a good therapeutic compliance. A significant correlation between D-glucaric acid excretion and drug score was obtained (r=0.508, p<0.001). When the interindividual variation was diminished by assessing the changes of these variables in the same subjects, the correlation was better (r=0.836, p<0.001). However, a statistical significance was not attained between the gamma-glutamyltransferase or beta-glucuronidase and drug score changes. Therefore the urinary excretion of D-glucaric acid appears to be more sensitive to changes in anticonvulsant drug score than serum gamma-glutamyltransferase and beta-glucuronidase.
Buscar no Google
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Ácido Glucárico
/
Anticonvulsivantes
Tipo de estudo:
Observational_studies
/
Prognostic_studies
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Clin Lab
Assunto da revista:
TECNICAS E PROCEDIMENTOS DE LABORATORIO
Ano de publicação:
2002
Tipo de documento:
Article
País de afiliação:
Espanha